was established in April 2018 and is located in Rizhao Economic and Technological Development Zone, Shandong Province. It is a high-tech enterprise specializing in the research and development, production, and sales of biological products and pharmaceutical raw materials. The company has a total investment of 500 million yuan and currently has about 300 employees. It has established a production system that meets GMP standards and has been recognized as a high-tech enterprise and a provincial-level specialized and innovative small and medium-sized enterprise. The company has approximately 260 reaction equipment and can produce 3000 tons of active pharmaceutical ingredients annually. Its products, such as mesalazine, phenylfluorenone, atorvastatin, ticagrelor, etc., are exported to countries and regions in Europe, America, Southeast Asia, and other regions.